Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click on 'Find out more' to see our Cookie statement.

A radical culture change in the NHS and across the health data and medical technology community is needed to ensure the NHS can deliver the benefits of new health technologies, says a new report co-authored by a University of Oxford scientist.

A stethoscope next to a laptop

The report, published by the Academy of Medical Sciences, outlines principles that must be adopted by the NHS and medical industry so that digital information about patients can be used in smarter, more joined-up ways to revolutionise healthcare and support life-saving research.

'We are already seeing digital technologies that empower patients to manage their own health, for example by monitoring their own condition at home,' said Professor Lionel Tarassenko, Head of the Department of Engineering Science at the University of Oxford and a member of the report’s steering committee.

'Technology will only evolve and get more sophisticated to have a bigger impact on healthcare in the NHS in the next ten years,' Professor Tarassenko added.

Putting into action the set of principles recommended in the Academy’s report will enable organisations, including the NHS and medical technology companies, to respect and protect the privacy, rights and choices of patients and the public. The principles will help provide safeguards to support patient data being used in ways that are fair, and will enable all NHS patients to benefit from the use of health technologies using patient data.

Health technologies that are becoming increasingly important include wearable devices, mobile phone apps and intelligent monitoring devices. Smart insulin pumps for diabetes, artificial intelligence assisted pregnancy ultrasound scans, and houses designed with smart technology to monitor and support dementia patients and their carers, are examples given in the report where patient data are already being used to develop health technologies.

The report highlights the potential of the NHS to become a world leader in the use of patient data for technologies to improve healthcare, and emphasises that patients and the public expect the NHS to keep control of patient data. It calls for action to be taken so the NHS can evolve into a system that learns from itself, feeding back digital information about patients and using technology to support, not replace, face-to-face healthcare. The NHS must also share in the wider benefits of contributing patient data for these new technologies.

Professor Tarassenko said: 'If we are going to reap the benefits of these advances, we must act now. We need to see a widespread increase in digital health literacy throughout the NHS, with the full involvement of patients and the public. We also need to think carefully how we regulate and evaluate digital health products, especially when they include artificial intelligence, so that healthcare professionals and patients know that they are safe and reliable, and improve patient outcomes.'

The group based their discussions on a programme of dialogue commissioned from Ipsos MORI that explored public, patient and healthcare professionals’ views on the future use of technologies that use patient data. Workshops were held in Cardiff, Sheffield and London, involving around 100 people from a wide range of backgrounds, some with long- and short-term mental and physical health conditions, and healthcare professionals including GPs, nurses, paramedics and hospital consultants. The Ipsos MORI report of these workshops is also published today.

A follow-up meeting gave an opportunity for the NHS, regulators, funders, policy makers, data and medical technology companies and the pharmaceutical industry to contribute their views. This Academy policy project was partly funded by a grant from the UK Department for Business, Energy and Industrial Strategy.

Professor Sir Robert Lechler PMedSci, President of the Academy of Medical Sciences, added: 'This report is based on high-quality, in depth conversations with members of the public, hospital doctors, GPs and nurses. We are calling for the NHS, regulators, industry and other key stakeholders to work together to adopt the principles set out in this report to make sure that patient data is used in a fair, transparent, safe and effective way.'

The report can be read in full online, or find out more about Professor Lionel Tarassenko’s work.

Story courtesy of the University of Oxford News Office

Similar stories

Averting an antibiotics apocalypse: major funding announced to tackle resistance to antibiotics

A cross-disciplinary team from the Universities of Oxford, Ulster and UCL have announced major funding from EPSRC to tackle the growing challenge of Antimicrobial Resistance (AMR).

COVID-19 lockdowns significantly reduced transmission of invasive bacterial diseases

A new international study involving University of Oxford researchers has conclusively demonstrated that national lockdowns and public health campaigns introduced at the start of the pandemic have reduced the transmission of bacteria that cause respiratory infections.

Floating ocean plastic can get a boost to its wave-induced transport because of its size

Plastic pollution and other ocean debris are a complex global environmental problem. Every year, ten million tonnes of plastic are estimated to be mismanaged, resulting in entry into the ocean, of which half will float initially. Yet, only 0.3 million tonnes of plastic can be found floating on the surface of the ocean. Where has the rest of the plastic gone?

Oxford researchers elected to Royal Society

Six scientists from the University of Oxford, including four from MPLS, have joined the Royal Society as Fellows.

Rapid evolution and host immunity drive the rise and fall of antibiotic resistance during acute infection

Antibiotic resistance poses a serious threat to human health, but how resistance emerges during infections remains poorly understood.

Oxford University and Prenetics announce landmark collaboration to scale rapid testing tech globally

Today, the University of Oxford, Prenetics Limited, a global leader in diagnostics and genetic testing, and Oxford Suzhou Centre for Advanced Research (OSCAR) have signed collaboration agreements to further develop the award-winning OxLAMP technology, a rapid, molecular testing technology for infectious diseases.